TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees January 6, 1984